The contribution of aberrant Wnt signalling to neuronal and vascular pathology in retinal disease

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Neuronal damage and vascular abnormalities are features shared by many retinal diseases. We will use a novel transgenic model to study the contributions of aberrant Wnt signalling in retinal neuronal and vascular pathology, and also, to test strategies for neuroprotection and inhibition of vascular abnormalities. Success in the project may identify novel therapeutic targets leading to safer and more effective treatments for retinal diseases.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $561,342.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Wnt signalling | anti-angiogenesis | glial cells | neuroprotection | retinal degeneration | retinal neovascularisation | transgenic model